Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation

Simplification of chemical processes and increase in activity and metastability of the compounds. 2. Essence Preparation of olanzapine for peroral administration which comprises a bulking agent, a binder, a disintegrant, a lubricant and additionally a polymer coating selected from the group consisti...

Full description

Saved in:
Bibliographic Details
Main Authors Cochram, George, R, Morris, Tommy, C
Format Patent
LanguageEnglish
Published 05.10.1999
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Simplification of chemical processes and increase in activity and metastability of the compounds. 2. Essence Preparation of olanzapine for peroral administration which comprises a bulking agent, a binder, a disintegrant, a lubricant and additionally a polymer coating selected from the group consisting of hydroxypropyl methylcellulose, hydroxyethyl cellulose, methylhydroxyethylcellulose, polyvinyl pyrrolidone, acrylic acid, dimethylaminoethyl metacrylatemethylacrylate acid ester copolymer, methylcellulose and ethylcellulose, process for its production and use against psychosis, schizophasia, schizophasia-like disorders, slight anxieties, gastro-intestinal disturbances and acute maniacal syndromes. 3. Field of Application Chemistry, in particular organic chemistry, medicine. 3 ind. 14 dep. cl.
AbstractList Simplification of chemical processes and increase in activity and metastability of the compounds. 2. Essence Preparation of olanzapine for peroral administration which comprises a bulking agent, a binder, a disintegrant, a lubricant and additionally a polymer coating selected from the group consisting of hydroxypropyl methylcellulose, hydroxyethyl cellulose, methylhydroxyethylcellulose, polyvinyl pyrrolidone, acrylic acid, dimethylaminoethyl metacrylatemethylacrylate acid ester copolymer, methylcellulose and ethylcellulose, process for its production and use against psychosis, schizophasia, schizophasia-like disorders, slight anxieties, gastro-intestinal disturbances and acute maniacal syndromes. 3. Field of Application Chemistry, in particular organic chemistry, medicine. 3 ind. 14 dep. cl.
Author Morris, Tommy, C
Cochram, George, R
Author_xml – fullname: Cochram, George, R
– fullname: Morris, Tommy, C
BookMark eNqNij0OgkAUBrfQwr87rAfYAi2QFgPaqBT05AU-wibLe5tdLOT0GuMBrCaTmbVasDBW6v4I5PTB3DANL2fqwYLF5Bhn6SzN8JahSwnj09FkhTVxp6sgLWLUvQRt40fhKXzzVi17chG7HzdqXxb1-WrgpUH01IIxNZeiSrIsS9L0lB__ed4QWjhS
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID GEP19991778B
GroupedDBID EVB
ID FETCH-epo_espacenet_GEP19991778B3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:23:18 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_GEP19991778B3
Notes Application Number: GE1996AP03947
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991005&DB=EPODOC&CC=GE&NR=P19991778B
ParticipantIDs epo_espacenet_GEP19991778B
PublicationCentury 1900
PublicationDate 19991005
PublicationDateYYYYMMDD 1999-10-05
PublicationDate_xml – month: 10
  year: 1999
  text: 19991005
  day: 05
PublicationDecade 1990
PublicationYear 1999
RelatedCompanies ELI LILLI AND COMPANY
RelatedCompanies_xml – name: ELI LILLI AND COMPANY
Score 2.5031314
Snippet Simplification of chemical processes and increase in activity and metastability of the compounds. 2. Essence Preparation of olanzapine for peroral...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991005&DB=EPODOC&locale=&CC=GE&NR=P19991778B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1Dedis4PIkjfgtuarutDEfq1IawtUmVvI21TnMy2bBVhv95b7Jwv-pbkyJHccR_c5S4Ad4bONQNVIhVaL6UsHjAaG5xRVMdaFiddlmbreMfY74-e2eNEmzTgbVMLI_uEfsrmiChRCcp7JfV1uQ1iOfJt5fI-nuFS8eBFpqOkdbkYGr-OpjiW6YaBE9iKbZtDV_GfzFACdX1g7cAuutH6WhrcF2tdlVL-NineEeyFiC2vjqEh8hYc2Juf11qwP64T3jisZW95An6w4HPSo2OBtJ3T6BUBBbXE-6pAHq9EiRuIhy5o_SEX4XlK6joAgq4pmS1xKr57fRf5Kdx6bmSPKB5s-kOF6dDd3kE9g2Ze5OIcCBd9rqUZ7ydMMD1NuKGqPb3LkTUJWvfOBbT_xtP-D3gJh7JHgcyWX0GzWnyIa7TAVXwjSfcFfbuM6g
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJoxDdFjeJXTczeGmF0jD0sJvsClQ1ipuGNdFuJGNwIzJjw6z3qEF_0re2ll_Yu95Fe7w7gxtC5ZqBKpEJTE8qiNqORwRlFdayNo7jBkvHqvcMPWt1n9jDUhiV4W-fCyDqhn7I4IkpUjPKeS3092zxiOfJv5eI2muBSdueFpqMkRboYGr-6pjiW6Q76Tt9WbNvsuErwZA4kUNfb1hZso4vdXnU7cF-sVVbK7LdJ8fZhZ4DY0vwASiKtQsVed16rwq5fBLxxWMje4hCC_pxPiUp9gbSd0vAVARm1xPsyQx4vxQw3EA9d0KIhF-FpQoo8AIKuKZkscCq-a31n6RFce25odykebPRDhVHH3dyheQzlNEvFCRAuWlxLxrwVM8H0JOZGs6nqDY6sidG610-h9jee2n_AK6h0Q7836t0Hj2ewJ-sVyMj5OZTz-Ye4QGucR5eSjF9A_I_a
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Oral+2-Methyl-Thieno-Bemzodiazepine+Formulation+and+Process+for+is+Preparation&rft.inventor=Cochram%2C+George%2C+R&rft.inventor=Morris%2C+Tommy%2C+C&rft.date=1999-10-05&rft.externalDBID=B&rft.externalDocID=GEP19991778B